165 related articles for article (PubMed ID: 20504911)
1. Contribution of bradykinin B2 receptors to the inhibition by valsartan of systemic and renal effects of exogenous angiotensin II in salt-repleted humans.
Biggi A; Musiari L; Iori M; De Iaco G; Magnani G; Pelloni I; Pinelli S; Pelà GM; Novarini A; Cabassi A; Montanari A
J Pharmacol Exp Ther; 2010 Sep; 334(3):911-6. PubMed ID: 20504911
[TBL] [Abstract][Full Text] [Related]
2. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
Clayton JS; Clark KL; Johns EJ; Drew GM
Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 3rd communication: hemodynamic effects of valsartan in rats and dogs.
Hayashi N; Yamamoto S; Kometani M; Nakao K
Arzneimittelforschung; 1997 May; 47(5):620-5. PubMed ID: 9205775
[TBL] [Abstract][Full Text] [Related]
4. Bradykinin B(2) receptor does not contribute to blood pressure lowering during AT(1) receptor blockade.
LeFebvre J; Shintani A; Gebretsadik T; Petro JR; Murphey LJ; Brown NJ
J Pharmacol Exp Ther; 2007 Mar; 320(3):1261-7. PubMed ID: 17182977
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes.
Montanari A; Pelà G; Musiari L; Crocamo A; Boeti L; Cabassi A; Biggi A; Cherney DZ
Am J Physiol Renal Physiol; 2013 Jul; 305(1):F42-51. PubMed ID: 23657857
[TBL] [Abstract][Full Text] [Related]
6. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.
Rehman A; Rahman AR; Rasool AH
J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720
[TBL] [Abstract][Full Text] [Related]
7. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism.
Mitchell A; Rushentsova U; Siffert W; Philipp T; Wenzel RR
Clin Pharmacol Ther; 2006 Mar; 79(3):274-81. PubMed ID: 16513451
[TBL] [Abstract][Full Text] [Related]
8. Role of bradykinin B2 receptors in the developmental changes of renal hemodynamics in the neonatal rat.
el-Dahr SS; Yosipiv IV; Lewis L; Mitchell KD
Am J Physiol; 1995 Dec; 269(6 Pt 2):F786-92. PubMed ID: 8594872
[TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteers.
Gossmann J; Burkhardt R; Harder S; Lenz T; Sedlmeyer A; Klinkhardt U; Haak T; Geiger H; Scheuermann EH
Clin Pharmacol Ther; 2000 Nov; 68(5):501-9. PubMed ID: 11103753
[TBL] [Abstract][Full Text] [Related]
10. Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins.
Komers R; Cooper ME
Am J Physiol; 1995 Apr; 268(4 Pt 2):F588-94. PubMed ID: 7733315
[TBL] [Abstract][Full Text] [Related]
11. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
Munoz-Garcia R; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Casal MC; Cachofeiro V; Lahera V
J Hypertens; 1995 Dec; 13(12 Pt 2):1779-84. PubMed ID: 8903651
[TBL] [Abstract][Full Text] [Related]
12. Calcium channel blockade blunts the renal effects of acute nitric oxide synthase inhibition in healthy humans.
Montanari A; Lazzeroni D; Pelà G; Crocamo A; Lytvyn Y; Musiari L; Cabassi A; Cherney DZI
Am J Physiol Renal Physiol; 2017 May; 312(5):F870-F878. PubMed ID: 28179255
[TBL] [Abstract][Full Text] [Related]
13. Aliskiren reduces myocardial ischemia-reperfusion injury by a bradykinin B2 receptor- and angiotensin AT2 receptor-mediated mechanism.
Koid SS; Ziogas J; Campbell DJ
Hypertension; 2014 Apr; 63(4):768-73. PubMed ID: 24420538
[TBL] [Abstract][Full Text] [Related]
14. Role of kinins and angiotensin II in the vasodilating action of angiotensin converting enzyme inhibition in rat renal vessels.
Endlich K; Steinhausen M
J Hypertens; 1997 Jun; 15(6):633-41. PubMed ID: 9218183
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats.
Yoshida K; Kobayashi N; Ohno T; Fukushima H; Matsuoka H
J Hypertens; 2007 Aug; 25(8):1633-42. PubMed ID: 17620960
[TBL] [Abstract][Full Text] [Related]
17. Role of Mas receptor antagonist (A779) on pressure diuresis and natriuresis and renal blood flow in the absence of angiotensin II receptors type 1 and 2 in female and male rats.
Mansoori A; Oryan S; Nematbakhsh M
J Physiol Pharmacol; 2014 Oct; 65(5):633-9. PubMed ID: 25371522
[TBL] [Abstract][Full Text] [Related]
18. Fetal uninephrectomy in male sheep alters the systemic and renal responses to angiotensin II infusion and AT1R blockade.
Singh RR; Moritz KM; Wintour EM; Jefferies AJ; Iqbal J; Bertram JF; Denton KM
Am J Physiol Renal Physiol; 2011 Aug; 301(2):F319-26. PubMed ID: 21543419
[TBL] [Abstract][Full Text] [Related]
19. Intranasal angiotensin II in humans reduces blood pressure when angiotensin II type 1 receptors are blocked.
Derad I; Sayk F; Lehnert H; Marshall L; Born J; Nitschke M
Hypertension; 2014 Apr; 63(4):762-7. PubMed ID: 24420549
[TBL] [Abstract][Full Text] [Related]
20. Effect of experimental hyperglycaemia on renal haemodynamics in prediabetic patients with and without AT1 receptor blockade.
Frank H; Pscherer S; Fliser D; Heemann U
Eur J Clin Invest; 2010 May; 40(5):414-21. PubMed ID: 20534063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]